Unicorns in Switzerland
Dealroom tracks 42 unicorns headquartered in Switzerland — companies that reached a verified $1B+ valuation — worth $117B combined, plus 11 thoroughbreds generating $100M+ in annual revenue. Updated August 2026.
Every unicorn in Switzerland
All 42 companies headquartered in Switzerland that reached a verified $1B+ valuation, ranked by latest valuation. Click a company for its full Dealroom profile.
| # | Company | Sector | HQ | Founded | Valuation | Status |
|---|---|---|---|---|---|---|
| 1 | Actelion Pharmaceuticals | Biotech & Life Sciences | Allschwil | 1997 | $30B | IPO 2013 |
| 2 | On | eCommerce & Marketplaces | Zurich | 2010 | $12B | IPO 2021 |
| 3 | DFINITY | Internet Computer | Fintech | Zurich | 2016 | $9.5B | Private |
| 4 | Ypsomed | Health Tech & Medtech | Bern | 2003 | $4.9B | IPO 2004 |
| 5 | Temenos | Fintech | Geneva | 1993 | $4.7B | IPO 2003 |
| 6 | Sonar | Other B2B Software | Vernier | 2008 | $4.7B | Private |
| 7 | Sportradar | Other | St. Gallen | 2001 | $4B | IPO 2021 |
| 8 | Acronis | Cybersecurity | Schaffhausen | 2003 | $3.5B | Private |
| 9 | Terra Quantum | Other B2B Software | St. Gallen | 2018 | $3.5B | Public via SPAC 2026 |
| 10 | INFICON | Semiconductors | Bad Ragaz | 1996 | $3.5B | IPO 2000 |
| 11 | CRISPR Therapeutics | Biotech & Life Sciences | Switzerland | 2013 | $3.1B | IPO 2016 |
| 12 | Nexthink | Other B2B Software | Prilly | 2004 | $3B | Private |
| 13 | Climeworks | Energy | Zurich | 2009 | $2.8B | Private |
| 14 | Idorsia | Biotech & Life Sciences | Allschwil | 2017 | $2.6B | IPO 2017 |
| 15 | 21.co | Fintech | Zurich | 2018 | $2B | Private |
| 16 | AutoForm | Transportation | Freienbach | 1995 | $2B | Private |
| 17 | Implantica | Health Tech & Medtech | Switzerland | 2003 | $1.7B | IPO 2020 |
| 18 | Swixx Biopharma | Biotech & Life Sciences | Baar | 2014 | $1.6B | Private |
| 19 | NovoCure | Biotech & Life Sciences | Root | 2000 | $1.6B | IPO 2015 |
| 20 | MindMaze | Biotech & Life Sciences | Lausanne | 2012 | $1.5B | Private |
| 21 | MoonLake Immunotherapeutics | Biotech & Life Sciences | Zug | 2021 | $1.4B | Public via SPAC 2022 |
| 22 | NBE-Therapeutics | Biotech & Life Sciences | Basel | 2012 | $1.3B | Private |
| 23 | BETA CAE Systems | Aviation | Root | 1990 | $1.2B | Private |
| 24 | Araris Biotech | Biotech & Life Sciences | Wädenswil | 2019 | $1.1B | Private |
| 25 | Medartis | Health Tech & Medtech | Basel | 1997 | $1.1B | IPO 2018 |
| 26 | Orderfox | AI | Zurich | 2017 | $1.1B | Private |
| 27 | Beekeeper | Cybersecurity | Zurich | 2012 | $1.1B | Private |
| 28 | Scandit | AI | Zurich | 2009 | $1B | Private |
| 29 | Sygnum | Fintech | Zurich | 2018 | $1B | Private |
| 30 | VectivBio | Biotech & Life Sciences | Basel | 2019 | $1B | IPO 2021 |
| 31 | South Pole | Fintech | Zurich | 2006 | $1B | Private |
| 32 | vVardis | Health Tech & Medtech | Baar | 2019 | $1B | Private |
| 33 | Sensirion | Semiconductors | Zurich | 1998 | $981M | IPO 2018 |
| 34 | u-blox | Semiconductors | Zurich | 1997 | $882M | IPO 2007 |
| 35 | Kuros Biosciences | Biotech & Life Sciences | Zurich | 2000 | $835M | IPO 2016 |
| 36 | Energy Vault | Energy | Lugano | 2017 | $631M | IPO 2022 |
| 37 | Zur Rose Group | Biotech & Life Sciences | Frauenfeld | 1993 | $624M | IPO 2017 |
| 38 | Sophia Genetics | Biotech & Life Sciences | Saint-Sulpice | 2011 | $479M | IPO 2021 |
| 39 | Oculis | Biotech & Life Sciences | Switzerland | 2003 | $408M | Public via SPAC 2023 |
| 40 | Lastminute.com | eCommerce & Marketplaces | Chiasso | 1998 | $36M | IPO 2000 |
| 41 | ADC Therapeutics | Biotech & Life Sciences | Epalinges | 2011 | $27M | IPO 2020 |
| 42 | Leonteq | Fintech | Zurich | 2007 | $-3190M | IPO 2012 |
Thoroughbreds — the $100M+ revenue tier
Dealroom's revenue milestone: 11 Switzerland companies past $100M in annual revenue, proof of traction beyond paper valuations.
| # | Company | Sector | HQ | Founded | Valuation | Status |
|---|---|---|---|---|---|---|
| 1 | Oviva | Health Tech & Medtech | Zurich | 2013 | $1.4B | Private |
| 2 | Basilea Pharmaceutica | Biotech & Life Sciences | Allschwil | 2000 | $528M | IPO 2004 |
| 3 | Crescendo | AI | Geneva | 2023 | $500M | Private |
| 4 | SWISSto12 | Space | Renens | 2011 | $420M | Private |
| 5 | Trifork | AI | Feusisberg | 1996 | $400M | IPO 2021 |
| 6 | AC Immune | Biotech & Life Sciences | Lausanne | 2003 | $155M | IPO 2016 |
| 7 | SwissBorg | Fintech | Lausanne | 2017 | $138M | Private |
| 8 | Molecular Partners | Biotech & Life Sciences | Zurich | 2004 | $57M | IPO 2014 |
| 9 | Bexio | Fintech | Rapperswil-Jona | 2013 | $41M | Private |
| 10 | Bravofly | Aviation | Chiasso | 2006 | — | IPO 2014 |
| 11 | Proton | Cybersecurity | Plan-les-Ouates | 2014 | — | Private |
Frequently asked questions
How many unicorns are there in Switzerland?
Dealroom tracks 42 unicorns headquartered in Switzerland as of August 2026, worth $117B combined. 2 of them are valued at $10B or more.
What are the biggest unicorns in Switzerland?
The three most valuable are Actelion Pharmaceuticals, On, DFINITY | Internet Computer. Zurich is the top hub with 13 of them.
What counts as a unicorn — and what is a thoroughbred?
A unicorn is a company that reached a $1B+ valuation, verified by Dealroom. A thoroughbred is Dealroom's revenue-based tier: a startup-era company generating $100M+ in annual revenue — traction, not just paper valuation.